Bibliography
- Cappella C., Heitz P. H. U., Höfler H., Solcia E., Kloppel G. Revised classification of Neuro-endocrine tumours of the lung, pancreas and gut. Virch Arch, 1995, 425: 547–56.
- Evans A. B., Skibber J. M., Lee J. E. Non functioning islet cell carcinoma of the pancreas. Surgery, 1993: 1175–11.
- Bajetta E., Ferrari L., Martinetti A., Celio L., Procopio G., Artale S. et al. Chromogranin A, neuron specific enolase, carci-no-embryonic antigen and hydroxyindole acetic acid evaluation in patients with neuro-endocrine tumours. Cancer, 1999, 86: 85865.
- öberg K. Neuro-endocrine gastro-intestinal tumours. Oncology in practice, 1999, 1: 3–7.
- Yeo C. J., Wang B. H., Anthone G. J. et al. Surgical experience with pancreatic islet-cell tumours. Arch Surg, 1993, 128: 1143–8.
- Rösch T., Lightdale C. H. J., Botet J. F. et al. Localization of pancreatic endocrine tumours by endoscopic ultrasonography. N Engl J Med, 1992, 326: 1721–6.
- Kisher O., Bastian D., Bartsch D. et al. Localisation, malignant potential and surgical management of gastrinomas. World J Surg, 1998, 22: 651–8.
- Kolby L. et al. Somatostatine receptor types, octreatide scintigra-phy and clinical response to octreatide treatment in patients with neuro-endocrine tumours. World J Surg, 1998, 22: 679–83.
- Eriksson B., öberg K. Neuro-endocrine tumours of the pancreas. British Journal of Surgery, 2000, 87: 129–31.
- Norton J. A., Kivlen M., Li M., Schneider D., Chuter T., Jensen R. T. Morbidity and mortality of aggressive resection in patients with advanced neuro-endocrine tumours. Arch Surg, 2003, 138: 859–66.
- Proye C. Natural history of liver metastasis of gastro-entero-pancreatic neuro-endocrine tumours: place for chemo-emboliza-tion. World J Surg, 2001, 25: 685–8.
- Chu Q. D., Hill H. C., Douglass H. O. et al. Predictive factors associated with long-term survival in patients with neuroendocrine tumours of the pancreas. Annals of Surgical Oncology, 2002, 9: 855–62.